Paolo Tombesi, Chief Financial Officer at Epizyme, Inc. (EPZM), sold 1,805 shares at $16.15 ($29K) on 2020-06-26, disclosed to the SEC on 2020-06-30.
Scheduled sale ($29k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EPZM | SELL | 2020-03-26 | $19K | — | Filing → |